VF
LSTA icon

Virtu Financial’s Lisata Therapeutics LSTA Stock Holding History

Virtu Financial’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
58,782
+16,569
+39% +$59K 0.01% 937
2026
Q1 		$211K Buy
+42,213
New +$174K 0.01% 1003
2022
Q1 		– Sell
-10,684
Closed -$135K – 1791
2021
Q4 		$135K Buy
+10,684
New +$165K 0.01% 997
2021
Q1 		– Sell
-3,507
Closed -$75K – 1842
2020
Q4 		$75K Buy
+3,507
New +$83.2K 0.01% 1135
2019
Q3 		– Sell
-775
Closed -$26K – 1652
2019
Q2 		$26K Buy
+775
New +$34.4K ﹤0.01% 1315

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial's LSTA Position: Q2 2026 in Review

Virtu Financial increased its Lisata Therapeutics (LSTA) stake by 39% in Q2 2026, buying an estimated $59K and bringing the position to 58,782 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #937.

Virtu Financial first reported a position in LSTA in Q2 2019 and has held it in 5 quarters since. The position peaked at $211K in Q1 2026. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Virtu Financial held 58,782 shares of Lisata Therapeutics worth $200K as of Q2 2026.
  • Virtu Financial bought 16,569 Lisata Therapeutics shares in Q2 2026, an estimated $59K.
  • Lisata Therapeutics made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #937 holding.
  • Virtu Financial first reported a position in Lisata Therapeutics in Q2 2019 and has held it in 5 quarters since.
  • Virtu Financial's Lisata Therapeutics position peaked at $211K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.